Age, Biography and Wiki

Matthias Lütolf was born on 1973, is a Swiss biomedical engineer. Discover Matthias Lütolf's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 51 years old?

Popular As N/A
Occupation N/A
Age 51 years old
Zodiac Sign N/A
Born 1973
Birthday
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on . He is a member of famous Engineer with the age 51 years old group.

Matthias Lütolf Height, Weight & Measurements

At 51 years old, Matthias Lütolf height not available right now. We will update Matthias Lütolf's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Matthias Lütolf Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Matthias Lütolf worth at the age of 51 years old? Matthias Lütolf’s income source is mostly from being a successful Engineer. He is from . We have estimated Matthias Lütolf's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income Engineer

Matthias Lütolf Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1973

Matthias Lutolf (born in 1973, also known as Matthias Lütolf) is a bio-engineer and a professor at EPFL (École Polytechnique Fédérale de Lausanne) where he leads the Laboratory of Stem Cell Bioengineering.

He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models.

In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.

1998

Lutolf studied materials engineering at ETH Zurich where he graduated in 1998.

2002

In 2002, he received his PhD in biomedical engineering from ETH Zurich for his studies on cell-responsive hydrogels for tissue engineering and cell culture, in the group of Jeffrey Hubbell.

He completed postdoctoral studies in the laboratory of Helen Blau at Stanford University, where he worked on novel cell culture approaches for blood and muscle stem cells, so called synthetic niches.

2007

In 2007, he founded his own laboratory at EPFL, where he was promoted to associate professor in 2014 and full professor in 2018.

In 2007, Lutolf received the European Young Investigator (EURYI) Award by the European Science Foundation.

2014

From 2014 to 2018, he was director of EPFL's Institute of Bioengineering.

In June 2021, Lutolf became scientific director of the newly established Roche Institute for Translational Bioengineering in Basel, Switzerland.

Lutolf's laboratory develops in vitro organoids mimicking healthy and diseased tissues and organs.

Specifically, Lutolf uses bioengineering strategies to guide stem cell-based development to build novel organoids with improved reproducibility and physiological relevance for basic science and in vitro testing of drug candidates.

His team has developed approaches to generate organoids in fully controllable 3D matrices, and has contributed to the understanding of how extrinsic biochemical and physical factors control stem cell fate and organogenesis.

His team has developed concepts based on microfabrication, bioprinting, and microfluidics to improve the reproducibility, size, shape, and function of organoids.

2018

Since 2018, he is elected as member of the European Molecular Biology Organization (EMBO).

He serves as associate editor of The Company of Biologists' journal Development.